176 related articles for article (PubMed ID: 22227036)
1. p15(INK4b) plays a crucial role in murine lymphoid development and tumorigenesis.
Osei-Sarfo K; de Castro IP; Pellicer A
Carcinogenesis; 2012 Mar; 33(3):708-13. PubMed ID: 22227036
[TBL] [Abstract][Full Text] [Related]
2. Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15(INK4b).
Malumbres M; Pérez De Castro I; Hernández MI; Jiménez M; Corral T; Pellicer A
Mol Cell Biol; 2000 Apr; 20(8):2915-25. PubMed ID: 10733595
[TBL] [Abstract][Full Text] [Related]
3. Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis.
Xia Y; Liu Y; Yang C; Simeone DM; Sun TT; DeGraff DJ; Tang MS; Zhang Y; Wu XR
Nat Commun; 2021 Apr; 12(1):2047. PubMed ID: 33824349
[TBL] [Abstract][Full Text] [Related]
4. The Rgr oncogene induces tumorigenesis in transgenic mice.
Jiménez M; Pérez de Castro I; Benet M; García JF; Inghirami G; Pellicer A
Cancer Res; 2004 Sep; 64(17):6041-9. PubMed ID: 15342385
[TBL] [Abstract][Full Text] [Related]
5. p21 loss cooperates with INK4 inactivation facilitating immortalization and Bcl-2-mediated anchorage-independent growth of oncogene-transduced primary mouse fibroblasts.
Carbone CJ; Graña X; Reddy EP; Haines DS
Cancer Res; 2007 May; 67(9):4130-7. PubMed ID: 17483323
[TBL] [Abstract][Full Text] [Related]
6. The H3K36 demethylase Jhdm1b/Kdm2b regulates cell proliferation and senescence through p15(Ink4b).
He J; Kallin EM; Tsukada Y; Zhang Y
Nat Struct Mol Biol; 2008 Nov; 15(11):1169-75. PubMed ID: 18836456
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance and potential drug target of p15INK4B in multiple myeloma.
Li J; Bi L; Lin Y; Lu Z; Hou G
Drug Des Devel Ther; 2014; 8():2129-36. PubMed ID: 25382971
[TBL] [Abstract][Full Text] [Related]
9. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
10. FOXO transcription factor-dependent p15(INK4b) and p19(INK4d) expression.
Katayama K; Nakamura A; Sugimoto Y; Tsuruo T; Fujita N
Oncogene; 2008 Mar; 27(12):1677-86. PubMed ID: 17873901
[TBL] [Abstract][Full Text] [Related]
11. p16 is a major inactivation target in hepatocellular carcinoma.
Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H
Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001
[TBL] [Abstract][Full Text] [Related]
12. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
13. Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.
Latres E; Malumbres M; Sotillo R; Martín J; Ortega S; Martín-Caballero J; Flores JM; Cordón-Cardo C; Barbacid M
EMBO J; 2000 Jul; 19(13):3496-506. PubMed ID: 10880462
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals.
Wu X; Bekker-Jensen IH; Christensen J; Rasmussen KD; Sidoli S; Qi Y; Kong Y; Wang X; Cui Y; Xiao Z; Xu G; Williams K; Rappsilber J; Sønderby CK; Winther O; Jensen ON; Helin K
Cell Res; 2015 Nov; 25(11):1205-18. PubMed ID: 26470845
[TBL] [Abstract][Full Text] [Related]
16. Decreased proliferation and cell cycle arrest in neoplastic rat pituitary cells is associated with transforming growth factor-beta1-induced expression of p15/INK4B.
Frost SJ; Simpson DJ; Farrell WE
Mol Cell Endocrinol; 2001 May; 176(1-2):29-37. PubMed ID: 11369440
[TBL] [Abstract][Full Text] [Related]
17. Oct-1 is involved in the transcriptional repression of the p15(INK4b) gene.
Hitomi T; Matsuzaki Y; Yasuda S; Kawanaka M; Yogosawa S; Koyama M; Tantin D; Sakai T
FEBS Lett; 2007 Mar; 581(6):1087-92. PubMed ID: 17316622
[TBL] [Abstract][Full Text] [Related]
18. Loss of p15/Ink4b accompanies tumorigenesis triggered by complex DNA double-strand breaks.
Camacho CV; Mukherjee B; McEllin B; Ding LH; Hu B; Habib AA; Xie XJ; Nirodi CS; Saha D; Story MD; Balajee AS; Bachoo RM; Boothman DA; Burma S
Carcinogenesis; 2010 Oct; 31(10):1889-96. PubMed ID: 20663777
[TBL] [Abstract][Full Text] [Related]
19. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene.
Kotake Y; Nakagawa T; Kitagawa K; Suzuki S; Liu N; Kitagawa M; Xiong Y
Oncogene; 2011 Apr; 30(16):1956-62. PubMed ID: 21151178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]